1. Home
  2. EMBC vs IIIV Comparison

EMBC vs IIIV Comparison

Compare EMBC & IIIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EMBC
  • IIIV
  • Stock Information
  • Founded
  • EMBC 1924
  • IIIV 2012
  • Country
  • EMBC United States
  • IIIV United States
  • Employees
  • EMBC N/A
  • IIIV N/A
  • Industry
  • EMBC Medical/Dental Instruments
  • IIIV EDP Services
  • Sector
  • EMBC Health Care
  • IIIV Technology
  • Exchange
  • EMBC Nasdaq
  • IIIV Nasdaq
  • Market Cap
  • EMBC 788.4M
  • IIIV 720.4M
  • IPO Year
  • EMBC N/A
  • IIIV 2018
  • Fundamental
  • Price
  • EMBC $15.11
  • IIIV $30.58
  • Analyst Decision
  • EMBC Buy
  • IIIV Buy
  • Analyst Count
  • EMBC 2
  • IIIV 6
  • Target Price
  • EMBC $18.50
  • IIIV $34.33
  • AVG Volume (30 Days)
  • EMBC 507.0K
  • IIIV 193.0K
  • Earning Date
  • EMBC 08-08-2025
  • IIIV 08-07-2025
  • Dividend Yield
  • EMBC 3.90%
  • IIIV N/A
  • EPS Growth
  • EMBC 18.26
  • IIIV N/A
  • EPS
  • EMBC 1.42
  • IIIV 5.56
  • Revenue
  • EMBC $1,102,500,000.00
  • IIIV $248,271,000.00
  • Revenue This Year
  • EMBC N/A
  • IIIV N/A
  • Revenue Next Year
  • EMBC N/A
  • IIIV $4.56
  • P/E Ratio
  • EMBC $10.82
  • IIIV $5.60
  • Revenue Growth
  • EMBC N/A
  • IIIV 25.08
  • 52 Week Low
  • EMBC $9.20
  • IIIV $20.42
  • 52 Week High
  • EMBC $21.48
  • IIIV $33.44
  • Technical
  • Relative Strength Index (RSI)
  • EMBC 66.06
  • IIIV 50.97
  • Support Level
  • EMBC $14.51
  • IIIV $29.99
  • Resistance Level
  • EMBC $15.44
  • IIIV $31.20
  • Average True Range (ATR)
  • EMBC 0.50
  • IIIV 0.85
  • MACD
  • EMBC -0.04
  • IIIV -0.12
  • Stochastic Oscillator
  • EMBC 79.59
  • IIIV 49.29

About EMBC Embecta Corp.

Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

About IIIV i3 Verticals Inc.

i3 Verticals Inc offers integrated payment and software solutions to small and medium-sized businesses and organizations in strategic vertical markets. Its operating segment includes Public Sector and Healthcare. The company generates maximum revenue from the Public Sector segment.

Share on Social Networks: